Riskpilot← Back to searchSign inGet full accessHögsboläkarna AB
ABActiveOrg 5593023582Högsbogatan 40General medical practice activities · NACE 8621Est. 202123 employees
Revenue 2025
SEK 43,9M
+42% vs 2024
EBITDA margin
13.2%
+38% vs 2024
Equity ratio
48.2%
Financial strength
Net profit 2025
SEK 3,8M
+38% vs 2024
| Revenue | SEK 43,9M | +42% |
| EBITDA | SEK 5,8M | +38% |
| Net profit | SEK 3,8M | +38% |
| Total assets | SEK 11,9M | +28% |
| Equity | SEK 5,7M | +26% |
| Employees | 23 | — |
Legal name
Högsboläkarna AB
Org number
5593023582
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
16 februari 2021
Share capital
SEK 50 000
Employees
23 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva sjuk- och hälsovård samt därmed förenlig verksamhet.
Address
Högsbogatan 40
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 2 119 | 16 477 | 31 050 | 43 949 |
| Staff expenses | — | — | — | −14 153 | −20 301 |
| EBITDA | — | −385 | 2 819 | 4 228 | 5 814 |
| Depreciation & amort. | −0 | −161 | −487 | −590 | −894 |
| EBIT | 0 | −546 | 2 332 | 3 639 | 4 920 |
| Net financials | — | −69 | −241 | −113 | −88 |
| Profit before tax | 0 | −615 | 2 064 | 3 473 | 4 803 |
| Tax | −0 | −0 | −306 | −726 | −1 004 |
| Net profit | 0 | −615 | 1 758 | 2 746 | 3 799 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 100 | 3 961 | 5 846 | 9 280 | 11 908 |
| Equity | 50 | 35 | 1 793 | 4 539 | 5 738 |
| Long-term debt | 1 050 | 3 023 | 1 730 | 739 | 422 |
| Short-term debt | 0 | 903 | 2 324 | 4 002 | 5 748 |
| Total debt | 1 050 | 3 926 | 4 054 | 4 741 | 6 170 |
EBITDA margin
13.2%
This company
15.8%
Market median
-16% vs market
20212025
Equity ratio
48.2%
This company
38.2%
Market median
+26% vs market
20212025
Return on equity
66.2%
This company
18.4%
Market median
+260% vs market
20212025
Net profit margin
8.6%
This company
8.1%
Market median
+6% vs market
20212025
Asset turnover
3.69×
This company
1.12×
Market median
+229% vs market
20212025
Debt / equity
1.08×
This company
0.62×
Market median
-74% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
AJ Chief Executive Officer | Chief Executive Officer | 2022 |
SK Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
SJ | Audit | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Äldrehälsan Göteborg AB
Högsboläkarna AB Board members of Högsboläkarna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anette Jessica Bergerheim | Chief Executive Officer | 0 companies |
| Sara Katarina Tengvall | Deputy Chief Executive Officer | 0 companies |
| Sven Johan Paul Ahlberg | Audit | 0 companies |
| Markus Oskar Bergerheim | Board of Directors | 0 companies |
| Olof Anders Tengvall | Chairman | 0 companies |